The historical rank and industry rank for Deccan Health Care's FCF Margin % or its related term are showing as below:
BOM:542248'
s FCF Margin % Range Over the Past 10 Years
Min: -21.53 Med: -3.09 Max: 20.46
Current: -7.56
During the past 11 years, the highest FCF Margin % of Deccan Health Care was 20.46%. The lowest was -21.53%. And the median was -3.09%.
BOM:542248's FCF Margin % is ranked worse than 70.37% of 962
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs BOM:542248: -7.56
Deccan Health Care FCF Margin % Related Terms
Deccan Health Care FCF Margin % Historical Data
* Premium members only.
The historical data trend for Deccan Health Care's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Deccan Health Care's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Deccan Health Care FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Deccan Health Care's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Deccan Health Care's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Deccan Health Care (BOM:542248) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Deccan Health Care and its competitors. According to the industry distribution chart, Deccan Health Care ranks #677 out of 962 companies in the Drug Manufacturers industry, placing it in the top 70.4%.
Is Deccan Health Care's FCF Margin % too high?
Deccan Health Care's current FCF Margin % is 0.00%. Based on the distribution chart, Deccan Health Care ranks #677 out of 962 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Deccan Health Care has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deccan Health Care's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Deccan Health Care ranks #677 out of 962 companies for FCF Margin %. This places Deccan Health Care in the lower half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Deccan Health Care and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Deccan Health Care's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deccan Health Care stock overvalued right now?
Based on GuruFocus' analysis, Deccan Health Care (BOM:542248) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹26.20, compared to a current price of ₹13.43 — trading 48.7% below its estimated fair value. The current FCF Margin % is 0.00%. Deccan Health Care's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Deccan Health Care (BOM:542248), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Deccan Health Care (BOM:542248) Overvalued in 2026?
Based on GuruFocus' analysis, Deccan Health Care stock appears to be undervalued.
The current stock price of ₹13.43 is trading 48.7% below its estimated GF Value™ of ₹26.20.
GuruFocus considers Deccan Health Care to be Significantly Undervalued.
Key valuation signals for BOM:542248:
FCF Margin %: 0.00%
GF Value™: ₹26.20 vs. price of ₹13.43 (48.7% below fair value)
No single metric tells the full story. See the BOM:542248 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deccan Health Care Ltd is into developing, manufacturing, and marketing a broad range of healthcare products, including nutraceutical, cosmeceutical, and ayurveda products (Fast Moving Consumer Health Products). Its products are Nutraceutical Food Products and other supplements and medicines. The company is operating in a single segment of manufacturing of nutraceutical products. The company operates in India as well as exports its products to other countries, and the majority of its revenue comes from India.
81GF Score
Get the complete analysis for BOM:542248
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542248 has been successfully added to your 
